Home / Crime and Justice / Abbott Faces NEC Lawsuit Trial Over Infant Formula
Abbott Faces NEC Lawsuit Trial Over Infant Formula
4 Mar
Summary
- A Chicago trial begins for families alleging baby formula caused infant bowel disease.
- Hundreds of lawsuits accuse Abbott of failing to warn about necrotizing enterocolitis risk.
- Recent trials have yielded mixed results for companies and plaintiffs alike.
A Chicago trial has begun, focusing on a lawsuit alleging Abbott Laboratories' baby formula led to necrotizing enterocolitis (NEC) in premature infants. This case is one of hundreds accusing Abbott of not warning about the risks associated with its cow's milk-based formula for preterm babies.
Plaintiffs claim the formula increases the risk of NEC, a serious bowel condition with a high mortality rate, especially in premature newborns. Abbott denies these allegations, asserting the formula's importance for infants whose mothers cannot produce sufficient breast milk.
Recent legal battles over similar claims have produced varied results. One case saw Mead Johnson ordered to pay $60 million, while another jury awarded $495 million against Abbott. However, both verdicts are under appeal, and other trials have resulted in dismissals or new trials being ordered.
Regulatory bodies have suggested that the absence of breast milk, rather than formula itself, may be linked to increased NEC incidence. Despite these ongoing legal challenges, the focus remains on the potential risks to vulnerable infants.
